Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD20A4P (Ankyrin repeat domain 20 family member A4, pseudogene) is a pseudogene locus in the human genome and is classified as a non-protein-coding genetic element[2]. It shares sequence similarity with protein-coding ankyrin repeat domain genes but contains mutations or deletions that prevent translation into a functional ankyrin-repeat-containing protein[2]. Pseudogenes like ANKRD20A4P may act as regulatory RNAs by competing for microRNA binding and, in rare cases for some pseudogenes, may influence the expression of their parental genes or participate in long non-coding RNA functions[5][3]. However, there is no experimental evidence that ANKRD20A4P produces a protein or has a documented healthy or disease-promoting biological function, nor is it recognized as a drug target or therapeutic receptor[2][1]. The gene is listed in major databases such as NCBI Gene (728747) and Ensembl (ENSG00000172014), but designated as a pseudogene without known clinical relevance[2][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 20 family member A4, pseudogene (ANKRD20A4P).